Immunoglobulin Market – Global Industry Insights, Trends, Opportunity Analysis, 2021-2027 the new research from Coherent Market Insights has announced report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The Immunoglobulin Market offers a summary of product specification, production analysis, technology, product type, considering key features such as gross margin, revenue & cost. Immunoglobulin Market report provides key statistics on the Market status of the Immunoglobulin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
Request for a Sample Report at – https://www.coherentmarketinsights.com/insight/request-sample/1712
Immunoglobulins are important components of the immune response because they recognise and attach to specific antigens such as bacteria and viruses, allowing them to be inhibited. Antibodies, also known as immunoglobulins, are glycoprotein molecules generated by plasma cells, or white blood cells. The immunological response to antibodies is both complex and selective. The biological characteristics, structure, target specificity, and distribution of the many immunoglobulin classes and subclasses (isotypes) differ. As a result, determining the immunoglobulin isotype can be helpful in understanding the complex humoral immune response.
Immunoglobulins are divided into three classes: IgG, IgA, and IgM, and are used to treat a variety of immunological and neurological disorders. These immunoglobulins can be given subcutaneously or intravenously. Multiple sclerosis, Primary Humoral Immunodeficiency (PIDD), Immune Thrombocytopenia Purpura (ITP), and autoimmune haemolytic anaemia are all treated with immunoglobulins. Immunoglobulins are also used in a variety of other fields, including haematology, neurology, immunology, dermatology, ophthalmology, nephrology, and rheumatology, which is driving the industry’s expansion.
Immunoglobulin Market Dynamics
Furthermore, the rising use of immunoglobulin is gaining popularity among pharmaceutical and biopharmaceutical companies for immunoglobulin research and development. Additionally, the industry is expected to benefit from an increase in the number of intravenous product approvals and clinical trials for novel therapeutic applications. For example, in May 2018, ADMA Biologics, Inc. announced that the company had received U.S. patent for treating respiratory infection. The patent covers the use of polyclonal immunoglobulin preparations for respiratory infection treatment, and the patent is valid until January 2035. Furthermore, Kedrioin Biopharma and Kamada Ltd. together in May 2018, launched two human-derived protein therapeutics companies announced that KEDRAB [Rabies Immune Globulin (Human)] has been launched in the U.S. as it has received U.S. Food and Drug Administration approval for passive, transient post-exposure prophylaxis of rabies infection, when given immediately after contact with a rabid or possibly rabid animal and concurrent with the rabies vaccine. The immunoglobulin market is likely to increase in the near future as a result of such advancements and launches in the industry. The growing prevalence of Primary Immunodeficiency Disease (PID) around the world is also propelling the immunoglobulin industry forward. According to the Centers for Disease Control and Prevention (CDC), the global incidence rate of hypogammaglobulinemia was around 2 per 100,000 people in 2012, and it is projected to rise in the near future. Furthermore, the growing senior population, which is more susceptible to disease due to the body’s reduced antibody immunological response, is driving up demand for immunoglobulin. However, the immunoglobulin market is projected to be restrained by high treatment costs, long-term adverse effects, a strict regulatory environment, and the advent of alternative medicines such as recombinant products.
Immunoglobulin Market – Regional Insights
North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa make up the worldwide Immunoglobulin market. In 2016, North America had the greatest share of the immunoglobulin market, followed by Europe. This is due to an increase in the number of immunoglobulins approved by the US Food and Drug Administration. For example, in 2016, Shire plc. announced the launch of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] the first and only Subcutaneous 20% treatment option without proline available in the U.S. to treat adult and pediatric patients (two years of age and older) with primary immunodeficiency (PI).
Moreover, some pharmaceutical and biotechnology businesses in Asia Pacific are working on global expansion of their products. For example, the South Korea’s Green Cross in November 2017, stated that the company expects to launch its immunodeficiency drugs in U.S. market in 2018, as company is been working with US FDA to prepare additional production-related data on its drug IVIG-SN, human normal immunoglobulin G for intravenous administration
Immunoglobulin Market – Competitive Analysis
The major players operating in the market include Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare. Other players in the immunoglobulin market include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products Co., Ltd., Option Care Enterprises, Inc., ADMA Biologics, Inc., and BioScrip, Inc.
Manufacturers of immunoglobulins are engaged in research and development to create novel immunoglobulin drugs. In January 2018, the National Institutes of Health awarded GigaGen a $3 million grant to explore innovative antibody therapeutics to advance its next-generation plasma therapy for patients with immune deficiencies. PlasmaCap IG (Intravenous Immunoglobulin or “IVIG”) was started in a phase III clinical trial by Evolve Biologics, a part of Therapure Biopharma Inc., in May 2018. PlasmaCap IG is an investigational IVIG replacement medication being tested in patients with Primary Immune Deficiency Diseases, both adults and children (PIDD). More such ongoing clinical trials are supporting growth of the immunoglobulin market.
Immunoglobulin Market Taxonomy:
By Mode of Delivery:
- North America
- Latin America
- Asia Pacific
- Middle East
Buy This Complete Business Report With Flat US $2000 Off @ https://www.coherentmarketinsights.com/promo/buynow/1712
Main points in Immunoglobulin Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Immunoglobulin Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Immunoglobulin Industry Impact
Chapter 2 Immunoglobulin Competition by Types, Applications, and Top Regions and Countries
2.1 Immunoglobulin (Volume and Value) by Type
2.3 Immunoglobulin (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Immunoglobulin Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Immunoglobulin Market Analysis
Chapter 6 East Asia Immunoglobulin Market Analysis
Chapter 7 Europe Immunoglobulin Market Analysis
Chapter 8 South Asia Immunoglobulin Market Analysis
Chapter 9 Southeast Asia Immunoglobulin Market Analysis
Chapter 10 Middle East Immunoglobulin Market Analysis
Chapter 11 Africa Immunoglobulin Market Analysis
Chapter 12 Oceania Immunoglobulin Market Analysis
Chapter 13 South America Immunoglobulin Market Analysis
Chapter 14 Company Profiles and Key Figures in Immunoglobulin Business
Chapter 15 Immunoglobulin Market Forecast (2021-2027)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027